Subsidies
Pick a company. You see which programmes comparable companies received over the last five years, how many of them, for what amount, and which the company itself did not receive.
BE 1042.632.016
EVN Farma
Manufacture of basic pharmaceutical products and pharmaceutical preparations · Flemish Brabant
Comparison group of 89 companies
The group is made of active legal entities with the same activity class (2120, Manufacture of basic pharmaceutical products and pharmaceutical preparations), in Flanders. Every size counts. The period starts in 2022.
- Flemish subsidies 49% of comparable This company: nothing in this register
- Federal transfers 1.1% of comparable This company: nothing in this register
- Wallonia-Brussels Federation 0% of comparable This company: nothing in this register
- EU budget 3.4% of comparable This company: nothing in this register
- EU research 2.2% of comparable This company: nothing in this register
Programmes EVN Farma did not receive according to the registers
At least 2 comparable companies received these programmes since 2022. The most shared come first. That others received a programme does not say whether this company qualifies or whether the programme is still open. The Flemish register publishes the names of its programmes in Dutch only: they appear here as it publishes them.
- Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille) For example ORFIT INDUSTRIES, DEBA PHARMA, BIVIT29% 26 of 89 companies median €1,968 awarded
- Vlaams opleidingsverlof (VOV) For example PFIZER MANUFACTURING BELGIUM, Janssen Pharmaceutica, Organon Heist25% 22 of 89 companies median €8,892 awarded
-
15% 13 of 89 companies median €13,973 awarded
- Vlaamse ondersteuningspremie (VOP) voor werkgevers (uitdovend stelsel) For example Janssen Pharmaceutica, Organon Heist, PFIZER MANUFACTURING BELGIUM12% 11 of 89 companies median €39,427 awarded
- Onderzoeksproject For example Janssen Pharmaceutica, Obulytix, Flindr Labs7.9% 7 of 89 companies median €618,305 awarded
- Ontwikkelingsproject For example GENZYME FLANDERS, Janssen Pharmaceutica, SIMABS5.6% 5 of 89 companies median €534,237 awarded
- Baekeland-mandaat For example Janssen Pharmaceutica, Obulytix, INTIBIO5.6% 5 of 89 companies median €327,865 awarded
- Werkbaarheidscheque (discontinued) For example LABORATORIA QUALIPHAR, -HEEL BELGIUM, LABORATORIA WOLFS5.6% 5 of 89 companies median €6,000 awarded
-
4.5% 4 of 89 companies median €442,093 awarded
-
4.5% 4 of 89 companies median €29,181 awarded
- Strategische transformatiesteun For example GENZYME FLANDERS, Janssen Pharmaceutica, ORFIT INDUSTRIES3.4% 3 of 89 companies median €2.0m awarded
- Innovatiemandaat For example Janssen Pharmaceutica, Ziphius, SIMABS3.4% 3 of 89 companies median €241,807 awarded
Show 5 more
- Kmo-groeisubsidie: steun voor groeitrajecten bij kmo's (discontinued) For example HEW PHARMA, INTIBIO, MONDOMED3.4% 3 of 89 companies median €50,000 awarded
-
3.4% 3 of 89 companies median €50,000 awarded
- Horizon Europe For example Janssen Pharmaceutica, Obulytix2.2% 2 of 89 companies median €2.2m EU contribution
- Decentralised Agencies, Joint Undertakings, EU institutions For example Obulytix, Janssen Pharmaceutica2.2% 2 of 89 companies median €1.5m attributed share
- Stagebonus (discontinued) For example GENZYME FLANDERS, BIVIT2.2% 2 of 89 companies median €1,000 awarded